| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/09/2007 | EP1272477B1 Pyrimidine compounds |
| 05/09/2007 | EP1268441B1 An intermediate and process for its synthesis |
| 05/09/2007 | EP1265907B9 Novel aryl fructose-1,6-bisphosphatase inhibitors |
| 05/09/2007 | EP1254169B1 Methods relating to modulation of th2 cell subset activity by modulation of xbp-1 activity |
| 05/09/2007 | EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 05/09/2007 | EP1183245B1 Selective npy (y5) antagonists |
| 05/09/2007 | EP1169058B1 Insulin-like growth factor binding protein-4 protease |
| 05/09/2007 | EP1168912B1 Organ arrest, protection and preservation |
| 05/09/2007 | EP1036078B1 Thienopyrimidines |
| 05/09/2007 | EP0708660B1 Compounds useful for preparing prodrugs of protein tyrosine kinase inhibitors |
| 05/09/2007 | CN1961073A Truncated DANCE, DANCE complex and method of using these |
| 05/09/2007 | CN1960977A Quinazoline derivative |
| 05/09/2007 | CN1960766A Novel G-CSF conjugates |
| 05/09/2007 | CN1960758A Remedy or preventive for arthritis |
| 05/09/2007 | CN1960757A Composition for increasing body height |
| 05/09/2007 | CN1959414A Method for filtering out substance of restraining gene orf10 interrelated to nosogenesis of SARS |
| 05/09/2007 | CN1958047A Method for preparing extractive of corn leaves |
| 05/09/2007 | CN1957973A Yuepingfeng effervesce granules, and preparation method |
| 05/09/2007 | CN1957968A Composition of medication for treating disease of altitude striss, preparation method and usage |
| 05/09/2007 | CN1957966A Method of preparing gel for clearing away the heat-evil and expelling superficial evils |
| 05/09/2007 | CN1957917A Method for preparing high oxygen large transfusion fluid |
| 05/09/2007 | CN1314696C 2-O-(beta-D-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 05/09/2007 | CN1314684C Synthesis method of saijiabin, its racemate and S-configuration, and preparation method of its amorphous powder |
| 05/09/2007 | CN1314683C Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
| 05/09/2007 | CN1314682C Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| 05/09/2007 | CN1314681C 2,3-diazanaphthalene derivatives with angiogenesis inhibiting activity |
| 05/09/2007 | CN1314674C Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 05/09/2007 | CN1314451C Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer |
| 05/09/2007 | CN1314435C Oral agent for relieving summer heal and its preparation method |
| 05/09/2007 | CN1314433C Chinese traditional medicine for treating Tourette |
| 05/08/2007 | US7216041 Methods of using the structure coordinates of molecules comprising an IMPDH-like binding pocket |
| 05/08/2007 | US7214800 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
| 05/08/2007 | US7214790 Genes and proteins encoded thereby |
| 05/08/2007 | US7214714 for treatment of renal diseases, cerebrovascular diseases and circulatory diseases |
| 05/08/2007 | US7214712 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 05/08/2007 | US7214700 Administering to a human patient an 2-oxindole-3-ylidenyl) acetic acid derivatives which modulate the activity of protein kinases and effective to treat disorders related to abnormal protein kinase activity, such as cancer |
| 05/08/2007 | US7214697 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 05/08/2007 | US7214692 Medical use for tachykinin antagonists |
| 05/08/2007 | US7214690 For therapy of acne, male- pattern baldness, sexual dysfunction, impotence, wasting diseases, hirsutism, hypogonadism, prostatic hyperplasia, osteoporosis, cancer cachexia, and hormone-dependent cancers |
| 05/08/2007 | US7214689 Isoquinoline compounds |
| 05/08/2007 | US7214688 Compounds |
| 05/08/2007 | US7214687 Quinuclidine derivatives and medicinal compositions containing the same |
| 05/08/2007 | US7214682 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 05/08/2007 | US7214680 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors |
| 05/08/2007 | US7214678 Having antiinflammatory, anti-pyretic and anti-diarrheal properties |
| 05/08/2007 | US7214677 Benzamide, heteroarylamide and reverse amides |
| 05/08/2007 | US7214674 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors |
| 05/08/2007 | US7214673 For therapy of psychosis and bipolar disorder |
| 05/08/2007 | US7214670 Administering to a post menopausal woman an effective amount of 2-methylene -19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3 |
| 05/08/2007 | US7214667 Drugs against articular failure |
| 05/08/2007 | US7214665 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof |
| 05/08/2007 | US7214663 The prodrug of the invention is a modified form of a therapeutic agent and comprises a therapeutic agent, an oligopeptide of three amino acids, a stabilizing group and, optionally, a linker group. The prodrug is cleavable by a |
| 05/08/2007 | US7214661 Methods of therapy with thrombin derived peptides |
| 05/08/2007 | US7214518 For therapy of diseases of cell proliferation |
| 05/08/2007 | US7214507 Plant enzymes for bioconversion |
| 05/08/2007 | US7214483 KCNQ2 and KCNQ3—potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies |
| 05/08/2007 | US7214380 Composition of an allergen that causes Th2-type T cell response in a susceptible individual, Listeria adjuvant, and a pharmaceutically acceptable carrier; treating allergies associated with an established allergen specific Th2-type T cell response |
| 05/08/2007 | CA2443216C Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine |
| 05/08/2007 | CA2373990C Pyrrolotriazine inhibitors of kinases |
| 05/08/2007 | CA2342950C New process for preparing 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thia zepine and application in the synthesis of tianeptine |
| 05/08/2007 | CA2339528C Hexahydropyrazolo[4,3-c]pyridine metabolites |
| 05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 05/08/2007 | CA2306837C Treatment of female sexual dysfunction |
| 05/08/2007 | CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/08/2007 | CA2228492C Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
| 05/08/2007 | CA2207120C Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation |
| 05/08/2007 | CA2185489C Cyclic adhesion inhibitors |
| 05/03/2007 | WO2007050720A1 Loteprednol etabonate against vascular dysfunction in the eye |
| 05/03/2007 | WO2007049917A1 The composition comprising extract of cinnamomum cassia bark for improving normal flora and enhancing immune response |
| 05/03/2007 | WO2007049820A1 Heterocyclic amide compound and use thereof |
| 05/03/2007 | WO2007049819A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient |
| 05/03/2007 | WO2007049818A1 Anti-fatty liver, anti-obesity or hypolipidemic composition |
| 05/03/2007 | WO2007049798A1 Novel benzoxathiin derivative |
| 05/03/2007 | WO2007049796A2 Resveratrol and/or grape leaf extract as i. a. endurance improver, anti-aging agent, muscle strength improver |
| 05/03/2007 | WO2007049771A1 Compound containing basic group and use thereof |
| 05/03/2007 | WO2007049757A1 Inhibitor of osteoclast formation, composition for oral administration and prophylactic or therapeutic agent for bone disease comprising lactoferrin-containing liposome |
| 05/03/2007 | WO2007049708A1 Ultrasonic cancer therapy accelerator and cytotoxic agent |
| 05/03/2007 | WO2007049642A1 Regulator of capsaicin receptor activity and pharmaceutical composition using the same |
| 05/03/2007 | WO2007049624A1 Preventives/remedies for cancer |
| 05/03/2007 | WO2007049532A1 Aminodihydrothiazine derivative |
| 05/03/2007 | WO2007049472A1 Human monoclonal antibody binding to human gm-csf and antigen-binding site thereof |
| 05/03/2007 | WO2007049359A1 Method of controlling glucose metabolism |
| 05/03/2007 | WO2007048803A1 Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
| 05/03/2007 | WO2006024770A8 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 05/03/2007 | WO2005092069A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 05/03/2007 | US20070099990 N-(3-(p-Isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide or a salt thereof; cerebrovascular disorders |
| 05/03/2007 | US20070099981 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/03/2007 | US20070099980 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/03/2007 | US20070099956 Nitrogen-containing heterocyclic derivatives having 2, 6-disubstituted styryl |
| 05/03/2007 | US20070099953 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 05/03/2007 | US20070099932 External preparation for athlete's foot treatment |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099914 Piperidine Derivatives |
| 05/03/2007 | US20070099906 Combinations for the treatment of noeplastic disorders |
| 05/03/2007 | US20070099899 Heterocyclic dihydropyrimidine compounds |
| 05/03/2007 | US20070099888 Inflammation Inhibitor Comprising Zinc Salt of Acylamino Acid |
| 05/03/2007 | US20070099870 Lipid analogs for combating tumors |
| 05/03/2007 | US20070099853 Agent for improving physiological motor functions |
| 05/03/2007 | US20070099849 Co-Therapy for the Treatment of Migraine Comprising Anticonvulsant Derivatives and Anti-Migraine Agents |
| 05/03/2007 | US20070099836 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |